Valeris Hires Biopharma Veteran Scott Filosi as Chief Commercial Officer
Event summary
- Valeris appoints Scott Filosi as Chief Commercial Officer on April 7, 2026.
- Filosi brings nearly three decades of commercial leadership experience in biopharma.
- He previously led market access and pricing at Verona Pharma and served as CEO of Luzsana Bio and Mirror Bio.
- Valeris works with over 500 life sciences customers and supports millions of patients.
The big picture
Valeris' appointment of Scott Filosi underscores the company's focus on enhancing commercialization capabilities in the life sciences sector. The move comes as biopharma companies increasingly seek integrated solutions to navigate complex market access and patient support challenges. With over 500 customers, Valeris is positioning itself as a key player in improving healthcare value chain efficiency.
What we're watching
- Commercial Execution
- How Filosi's experience will accelerate Valeris' growth and strengthen partner relationships.
- Market Positioning
- Whether Valeris can sustain its integrated service model in a rapidly evolving healthcare landscape.
- Patient Access
- The pace at which Valeris expands its patient support services to improve medication access and adherence.